The regulatory role of nerve growth factor and its receptor system in fibroblast‐like synovial cells

References

• Aloe L. Nerve growth factor and neuroimmune responses: basic and clinical observations. Arch Physiol Biochem 2001; 109: 354–6
   PubMedGoogle Scholar
• Hattori A., Iwasaki S., Murase K., Tsujimoto M., Sato M., Hayashi K., et al. Tumor necrosis factor is markedly synergistic with interleukin 1 and interferon gamma in stimulating the production of nerve growth factor in fibroblasts. FEBS Lett 1994; 340: 177–80
   PubMed Web of Science ®Google Scholar
• Heese K., Hock C., Otten U. Inflammatory signals induce neurotrophin expression in human microglial cells. J Neurochem 1998; 70: 699–707
   PubMed Web of Science ®Google Scholar
• Farber E. M., Raychaudhuri S. P. Is psoriasis a neuroimmunologic disease?. Int J Dermatol 1999; 38: 12–15
   PubMed Web of Science ®Google Scholar
• Waller H. A., Butler M. G., McClean J. G., Dowd G. S., Scott D. L. Localisation of fibronectin mRNA in the rheumatoid synovium by in situ hybridisation. Ann Rheum Dis 1992; 51: 735–40
   PubMed Web of Science ®Google Scholar
• Henderson B., Pettipher E. R. The synovial lining cell: biology and pathobiology. Semin Arthritis Rheum 1985; 15: 1–32
   PubMed Web of Science ®Google Scholar
• Aloe L., Probert L., Kollias G., Bracci‐Laudiero L., Spillantini M. G., Levi‐Montalcini R. The synovium of transgenic arthritic mice expressing human tumor necrosis factor contains a high level of nerve growth factor. Growth Factors 1993; 9: 149–55
   PubMed Web of Science ®Google Scholar
• Manni L., Lundeberg T., Fiorito S., Bonini S., Vigneti E., Aloe L. Nerve growth factor release by human synovial fibroblasts prior to and following exposure to tumor necrosis factor‐alpha, interleukin‐1 beta and cholecystokinin‐8: the possible role of NGF in the inflammatory response. Clin Exp Rheumatol 2003; 21: 617–24
   PubMed Web of Science ®Google Scholar
• Levi‐Montalcini R., Aloe L., Alleva E. A role for nerve growth factor in nervous, endocrine and immune systems. Prog Neuroendocrine Immunol 1990; 3: 1–10
   Google Scholar
• Valencia X., Higgins J. M. G., Kiener H. P., Lee D. M., Podrebarac T. A., Dascher C. C., et al. Cadherin‐11 provides specific cellular adhesion between fibroblast‐like synoviocytes. J Exp Med 2004; 200: 1673–9
   PubMed Web of Science ®Google Scholar
• Shang X. Z., Lang B. J., Issekutz A. C. Adhesion molecule mechanisms mediating monocyte migration through synovial fibroblast and endothelium barriers: role for CD11/CD18, very late antigen‐4 (CD49d/CD29), very late antigen‐5 (CD49e/CD29), and vascular cell adhesion molecule‐1 (CD106). J Immunol 1998; 160: 467–74
   PubMed Web of Science ®Google Scholar
• Giatromanolaki A., Sivridis E., Athanassou N., Zois E., Thorpe P. E., Brekken R. A., et al. The angiogenic pathway ‘vascular endothelial growth factor/flk‐1 (KDR)‐receptor’ in rheumatoid arthritis and osteoarthritis. J Pathol 2001; 194: 101–8
   PubMed Web of Science ®Google Scholar
• Tang L. L., Wang R., Tang X. C. Huperzine A protects SHSY5Y neuroblastoma cells against oxidative stress damage via nerve growth factor production. Eur J Pharmacol 2005; 519: 9–15
   PubMed Web of Science ®Google Scholar
• Olivieri G., Otten U., Meier F., Baysang G., Dimitriades‐Schmutz B., Müller‐Spahn F., et al. Oxidative stress modulates tyrosine kinase receptor A and p75 receptor (low‐affinity nerve growth factor receptor) expression in SHSY5Y neuroblastoma cells. Neurol Clin Neurophysiol 2002; 2: 2–10
   Google Scholar
• Otten U., Scully J. L., Ehrhard P. B., Gadient R. A. Neurotrophins: signals between the nervous and immune systems. Prog Brain Res 1994; 103: 293–305
   PubMed Web of Science ®Google Scholar
• Horigome K., Pryor J. C., Bullock E. D., Johnson E. M. Mediator release from mast cells by nerve growth factor. Neurotrophin specificity and receptor mediation. J Biol Chem 1993; 268: 14881–7
   PubMed Web of Science ®Google Scholar
• Pincelli C., Sevignani C., Manfredini R., Grande A., Fantini F., Bracci‐Laudiero L., et al. Expression and function of nerve growth factor and nerve growth factor receptor on cultured keratinocytes. J Invest Dermatol 1994; 103: 13–18
   PubMed Web of Science ®Google Scholar
• Yaar M., Eller M. S., DiBenedetto P., Reenstra W. R., Zhai S., McQuaid T., et al. The trk family of receptors mediates nerve growth factor and neurotrophin‐3 effects in melanocytes. J Clin Invest 1994; 94: 1550–62
   PubMed Web of Science ®Google Scholar
• Raychaudhuri S. K., Raychaudhuri S. P., Weltman H., Farber E. M. Effect of nerve growth factor on endothelial cell biology: proliferation and adherence molecule expression on human dermal microvascular endothelial cells. Arch Dermatol Res 2001; 293: 291–5
   PubMed Web of Science ®Google Scholar
• Meakin S. O., Shooter E. M. The nerve growth factor family of receptors. Trends Neurosci 1992; 15: 323–31
   PubMed Web of Science ®Google Scholar
• Patterson J. C., Childs G. V. Nerve growth factor and its receptor in the anterior pituitary. Endocrinology 1994; 135: 1689–96
   PubMed Web of Science ®Google Scholar
• Raychaudhuri S. P., Sanyal M., Weltman H., Raychaudhuri S. K. K252a, a high affinity NGF receptor blocker improves psoriasis: an in vivo study using the SCID mouse–human skin model. J Invest Dermatol 2004; 122: 812–19
   PubMed Web of Science ®Google Scholar
• El‐Banna S. M., Mahdi W. K., Ali B. A., Raouf M. M. Role of nerve growth factor in allergic and inflammatory lung diseases. J Microbiol Immunol Infect 2006; 39: 444–51
   PubMedGoogle Scholar
• Johansson M., Norrgard O., Forsgren S. Study of expression patterns and levels of neurotrophins and neurotrophin receptors in ulcerative colitis. Inflamm Bowel Dis 2007; 13: 398–409
   PubMed Web of Science ®Google Scholar
• Ulrich A., Schlessinger J. Signal transduction by receptors with tyrosine kinase activity. Cell 1990; 61: 203–12
   PubMed Web of Science ®Google Scholar
• Berg M. M., Sternberg D. W., Parada L. F., Chao M. V. K‐252a inhibits nerve growth factor‐induced trk proto‐oncogene tyrosine phosphorylation and kinase activity. J Biol Chem 1992; 267: 13–16
   PubMed Web of Science ®Google Scholar
• Dicou E., Masson C., Jabbour W., Nerriere V. Increased frequency of NGF in sera of RA and systemic lupus erythematosus patients. Neuroreport 1993; 5: 321–4
   PubMed Web of Science ®Google Scholar
• Halliday D. A., Zettler C., Rush R. A., Scicchitano R., McNeil J. D. Elevated nerve growth factor levels in the synovial fluid of patients with inflammatory joint disease. Neurochem Res 1998; 23: 919–22
   PubMed Web of Science ®Google Scholar
• Del Porto F., Aloe L., Lagana B., Triaca V., Nofroni I., D'Amelio R. Nerve growth factor and brain‐derived neurotrophic factor levels in patients with rheumatoid arthritis treated with TNF‐alpha blockers. Ann N Y Acad Sci 2006; 1069: 438–43
   PubMed Web of Science ®Google Scholar
• Rihl M., Kruithof E., Barthel C., De Keyser F., Veys E. M., Zeidler H., et al. Involvement of neurotrophins and their receptors in spondyloarthritis synovitis: relation to inflammation and response to treatment. Ann Rheum Dis 2005; 64: 1542–9
   PubMed Web of Science ®Google Scholar
• Wernicke D., Schulze‐Westhoff C., Petrow P., Bräuer R., Zacher J., Gay S., et al. Stimulation of collagenase 3 expression in synovial fibroblasts of patients with rheumatoid arthritis by contact with a three‐dimensional collagen matrix or with normal cartilage when coimplanted in NOD/SCID mice. Arthritis Rheum 2002; 46: 64–74
   PubMed Web of Science ®Google Scholar
• Turan B., Pfister K., Diener P. A., Hell M., Möller B., Boyvat A., et al. Soluble tumour necrosis factor receptors sTNFR1 and sTNFR2 are produced at sites of inflammation and are markers of arthritis activity in Behçet's disease. Scand J Rheumatol 2008; 37: 135–41
   PubMed Web of Science ®Google Scholar
• Jiao Z., Wang W., Jia R., Li J., You H., Chen L., Wang Y. Accumulation of FoxP3‐expressing CD4+CD25+ T cells with distinct chemokine receptors in synovial fluid of patients with active rheumatoid arthritis. Scand J Rheumatol 2007; 36: 428–33
   PubMed Web of Science ®Google Scholar
• Nguyen T. T., Gehrmann M., Zlacka D., Sosna A., Vavrincova P., Multhoff G., et al. Heatshock protein 70 membrane expression on fibroblast‐like synovial cells derived from synovial tissue of patients with rheumatoid and juvenile idiopathic arthritis. Scand J Rheumatol 2006; 35: 447–53
   PubMed Web of Science ®Google Scholar
• Cinelli M., Guiducci S., Del Rosso A., Pignone A., Del Rosso M., Fibbi G., et al. Piascledine modulates the production of VEGF and TIMP‐1 and reduces the invasiveness of rheumatoid arthritis synoviocytes. Scand J Rheumatol 2006; 35: 346–50
   PubMed Web of Science ®Google Scholar
• Thorpe L. W., Werrbach‐Perez K., Perez‐Polo J. R. Effects of nerve growth factor on the expression of IL‐2 receptors on cultured human lymphocytes. Ann N Y Acad Sci 1987; 496: 310–11
   PubMed Web of Science ®Google Scholar
• Raychaudhuri S. P., Jiang W. Y., Farber E. M., Schall T. J., Ruff M. R., Pert C. B. Upregulation of RANTES in psoriatic keratinocytes: a possible pathogenic mechanism for psoriasis. Acta Derm Venereol 1999; 79: 9–11
   PubMed Web of Science ®Google Scholar
• Lindsay R. M., Harmar A. J. Nerve growth factor regulates expression of neuropeptides genes in adult sensory neurons. Nature 1989; 337: 362–4
   PubMed Web of Science ®Google Scholar
• Indo Y. Genetics of congenital insensitivity to pain with anhidrosis (CIPA) or hereditary sensory and autonomic neuropathy type IV. Clinical, biological and molecular aspects of mutations in TRKA(NTRK1) gene encoding the receptor tyrosine kinase for nerve growth factor. Clin Auton Res 2002; 12((Suppl 1))I20–32
   PubMedGoogle Scholar
• Lewin G. R., Rueff A., Mendell L. M. Peripheral and central mechanisms of NGF induced hyperalgesia. Eur J Neurosci 1994; 6: 1903–12
   PubMed Web of Science ®Google Scholar